Evidence map›Paper›PMID 27043833›Full record

ArticleThe Permanente journal2016

Emergency Care of Patients with Acute Ischemic Stroke in the Kaiser Permanente Southern California Integrated Health System.

Kori Sauser-Zachrison, Ernest Shen, Zahra Ajani, William P Neil, Navdeep Sangha, Michael K Gould, Adam L Sharp

Abstract read
In one paragraph

Article in The Permanente journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kori Sauser-ZachrisonAssistant Professor in the Department of Emergency Medicine at Massachusetts General Hospital and Harvard Medical School in Boston. ksauser@mgh.harvard.edu.
Ernest ShenBiostatistician in the Department of Research and Evaluation for Kaiser Permanente Southern California in Pasadena. ernest.shen@kp.org.
Zahra AjaniNeurologist at the Sunset Medical Center in Los Angeles, CA. zahra.a.ajani@kp.org.
William P NeilNeurologist at the San Diego Medical Center in CA. william.p.neil@kp.org.
Navdeep SanghaNeurologist at the Sunset Medical Center in Los Angeles, CA. navdeep.x.sangha@kp.org.
Michael K GouldResearch Scientist in the Department of Research and Evaluation for Kaiser Permanente Southern California in Pasadena. michael.k.gould@kp.org.
Adam L SharpResearch Scientist in the Department of Research and Evaluation for Kaiser Permanente Southern California in Pasadena. adam.l.sharp@kp.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextTissue plasminogen activator (tPA) is underutilized for treatment of acute ischemic stroke.

objectiveTo determine whether the probability of tPA administration for patients with ischemic stroke in an integrated health care system improved from 2009 to 2013, and to identify predictors of tPA administration.

designRetrospective analysis of all ischemic stroke presentations to 14 Emergency Departments between 2009 and 2013. A generalized linear mixed-effects model identified patient and hospital predictors of tPA.

main outcome measuresPrimary outcome was tPA administration; secondary outcomes were door-to-imaging and door-to-needle times and tPA-related bleeding complications.

resultsOf the 11,630 patients, 3.9% received tPA. The likelihood of tPA administration increased with presentation in 2012 and 2013 (odds ratio [OR] = 1.75; 95% confidence interval [CI] = 1.26-2.43; and OR = 2.58; 95% CI = 1.90-3.51), female sex (OR = 1.27; 95% CI = 1.04-1.54), and ambulance arrival (OR = 2.17; 95% CI = 1.76-2.67), and decreased with prior stroke (OR = 0.47; 95% CI = 0.25-0.89) and increased age (OR = 0.98; 95% CI = 0.97-0.99). Likelihood varied by Medical Center (pseudo-intraclass correlation coefficient 13.5%). Among tPA-treated patients, median door-to-imaging time was 15 minutes (interquartile range, 9-23 minutes), and door-to-needle time was 73 minutes (interquartile range, 55-103 minutes). The rate of intracranial hemorrhage was 4.2% and 0.9% among tPA- and non-tPA treated patients (p < 0.001).

conclusionAcute ischemic stroke care improved over time in this integrated health system. Better understanding of differences in hospital performance will have important quality-improvement and policy implications.

Indexed as

Critical CareDelivery of Health Care, IntegratedCaliforniaFemaleFibrinolytic AgentsHumansMaleMedical AuditOutcome Assessment, Health CareRetrospective StudiesStrokeTissue Plasminogen ActivatorFibrinolytic AgentsTissue Plasminogen Activator

Identifiers

PMID27043833
PMCPMC4867819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.